The 10 analysts offering 12-month price forecasts for Syndax Pharmaceuticals Inc have a median target of 36.00, with a high estimate of 42.00 and a low estimate of 32.00. The median estimate represents a +148.10% increase from the last price of 14.51.
The current consensus among 11 polled investment analysts is to Buy stock in Syndax Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.82
Reporting Date Nov 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.